Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human von Willebrand factor

EU orphan designation number: EU/3/10/814   
Active ingredient: Recombinant human von Willebrand factor
Indication: Treatment of von Willebrand disease
Sponsor: Baxalta Innovations GmbH
Industriestraße 67, 1221 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Orphan designation EMA/OD/055/10 (2010)8599 of 26/11/2010
28/05/2015 Change of name and/or address of sponsor